Ram Jagadeesan

AI and ML in spine surgery has both transformative possibilities and notable challenges related to regulatory oversight, algorithmic bias, and clinical responsibility. We propose a governance model to tackle these important issues, ensuring the responsible use of AI tools. This framework introduces the SAIGE-R Index, a tool designed to measure AI system risks based on Clinical Volatility, System Integration Risk, and Data Integrity Confidence. This index supports a tiered oversight system, ranging from minimal checks for low-risk systems to thorough FDA reviews for high-risk applications. In addition, SAIGE sets specific validation standards focused on spine surgery outcomes. These include important differences in patient-reported measures and accuracy in pedicle screw placement, along with quarterly fairness checks to reduce demographic bias. The framework also describes a strong governance structure that focuses on ongoing clinician training, involvement from multiple stakeholders, and strict data security measures. It suggests a liability model that matches responsibility with the evaluated risk level of AI tools. By addressing validation, ethics, and accountability, the SAIGE Framework provides a foundation for safely and effectively incorporating AI into complex surgical settings. This approach encourages innovation while maintaining patient safety and clinical integrity.

Musculoskeletal (MSK) disorders remain a major global cause of disability, with diagnostic complexity arising from their heterogeneous presentation and multifactorial pathophysiology. Recent advances across imaging modalities, molecular biomarkers, artificial intelligence applications, and point-of-care technologies are fundamentally reshaping musculoskeletal diagnostics. This review offers a novel synthesis by unifying recent innovations across multiple diagnostic imaging modalities, such as CT, MRI, and ultrasound, with emerging biochemical, genetic, and digital technologies. While existing reviews typically focus on advances within a single modality or for specific MSK conditions, this paper integrates a broad spectrum of developments to highlight how use of multimodal diagnostic strategies in combination can improve disease detection, stratification, and clinical decision-making in real-world settings. Technological developments in imaging, including photon-counting detector computed tomography, quantitative magnetic resonance imaging, and four-dimensional computed tomography, have enhanced the ability to visualize structural and dynamic musculoskeletal abnormalities with greater precision. Molecular imaging and biochemical markers such as CTX-II (C-terminal cross-linked telopeptides of type II collagen) and PINP (procollagen type I N-propeptide) provide early, objective indicators of tissue degeneration and bone turnover, while genetic and epigenetic profiling can elucidate individual patterns of susceptibility. Point-of-care ultrasound and portable diagnostic devices have expanded real-time imaging and functional assessment capabilities across diverse clinical settings. Artificial intelligence and machine learning algorithms now automate image interpretation, predict clinical outcomes, and enhance clinical decision support, complementing conventional clinical evaluations. Wearable sensors and mobile health technologies extend continuous monitoring beyond traditional healthcare environments, generating real-world data critical for dynamic disease management. However, standardization of diagnostic protocols, rigorous validation of novel methodologies, and thoughtful integration of multimodal data remain essential for translating technological advances into improved patient outcomes. Despite these advances, several key limitations constrain widespread clinical adoption. Imaging modalities lack standardized acquisition protocols and reference values, making cross-site comparison and clinical interpretation difficult. AI-driven diagnostic tools often suffer from limited external validation and transparency (“black-box” models), impacting clinicians’ trust and hindering regulatory approval. Molecular markers like CTX-II and PINP, though promising, show variability due to diurnal fluctuations and comorbid conditions, complicating their use in routine monitoring. Integration of multimodal data, especially across imaging, omics, and wearable devices, remains technically and logistically complex, requiring robust data infrastructure and informatics expertise not yet widely available in MSK clinical practice. Furthermore, reimbursement models have not caught up with many of these innovations, limiting access in resource-constrained healthcare settings. As these fields converge, musculoskeletal diagnostics methods are poised to evolve into a more precise, personalized, and patient-centered discipline, driving meaningful improvements in musculoskeletal health worldwide.

Advancements in load-bearing tissue repair increasingly demand biomaterials that not only support structural integrity but also interact dynamically with the physiological environment. This review examines the latest progress in smart biomaterials designed for skeletal reconstruction, with emphasis on mechanoresponsive scaffolds, bioactive composites, and integrated microsensors for real-time monitoring. We explore material formulations that enhance osseointegration, resist micromotion-induced loosening, and modulate inflammatory responses at the bone–implant interface. Additionally, we assess novel fabrication methods—such as additive manufacturing and gradient-based material deposition—for tailoring stiffness, porosity, and degradation profiles to match host biomechanics. Special attention is given to sensor-augmented platforms capable of detecting mechanical strain, biofilm formation, and early-stage implant failure. Together, these technologies promise a new class of bioresponsive, diagnostic-capable constructs that extend beyond static support to become active agents in regenerative healing and post-operative monitoring. This multidisciplinary review integrates insights from materials science, mechanobiology, and device engineering to inform the future of implantable systems in skeletal tissue repair.

Spine-focused biomedical informatics has emerged as a critical frontier for applying artificial intelligence (AI) to improve diagnosis, prognosis, and intervention in complex musculoskeletal and neurodegenerative conditions. This review synthesizes recent developments in the integration of machine learning (ML), deep learning (DL), and natural language processing (NLP) within spine health ecosystems. We highlight convolutional neural networks for vertebral segmentation and disc classification, radiomic pipelines for quantitative MRI/CT biomarker extraction, and multimodal ML models for outcome prediction across degenerative, neoplastic, and traumatic pathologies. We examine spine-specific clinical decision support systems (CDSSs) that fuse structured EHR data with NLP-parsed reports, wearable biomechanics, and genomic signals to generate real-time, risk-adaptive treatment guidance. Emphasis is placed on explainable AI (XAI) frameworks—e.g., SHAP, LIME, Grad-CAM—that support interpretability and ethical accountability in AI-augmented decision-making. We analyze challenges in generalizability, privacy-preserving federated learning, and regulatory heterogeneity, with attention to evolving U.S. FDA guidance, EU AI Act obligations, and liability frameworks. Integrating epistemic transparency with computational scalability, this review offers a roadmap for translating AI-enhanced spine informatics into safe, equitable, and clinically trustworthy systems—advancing the goals of biomedical informatics by unifying predictive analytics with ethical and patient-centered care.

Spine connectomics and neural integration have redefined the spinal cord as a dynamic computational hub, pivotal for sensorimotor coordination and adaptive motor control. This review synthesizes advancements from 2015 to 2025, highlighting how high-density electrophysiology, optogenetics, and brain-machine interfaces (BMIs), including Neuralink’s high-resolution neural arrays, elucidate spinal circuit architecture and function. We explore predictive coding and Bayesian integration mechanisms within spinal networks, revealing their role in processing multimodal sensory inputs and modulating motor outputs. Cutting-edge technologies, such as Neuropixels-Cord probes and 7 Tesla axis-resolved fMRI, enable laminar-specific mapping, while computational models uncover small-world network properties and hierarchical organization. Clinical applications include closed-loop epidural stimulation for spinal cord injury (SCI) rehabilitation, memristive sensors for prosthetic feedback, and personalized neuromodulation for chronic pain and scoliosis. Neuralink’s bidirectional BMIs demonstrate potential in restoring motor and sensory functions post-SCI, though challenges like electrode stability persist. Ethical considerations, including equitable access and neurodata privacy, are critical as these technologies advance. Future directions involve AI-driven discovery, multi-omics integration, and non-invasive neuromodulation to achieve comprehensive spinal connectomes, promising precision therapies for neurological disorders and enhanced musculoskeletal health.

Degenerative joint disease remains a leading cause of global disability, with early diagnosis posing a significant clinical challenge due to its gradual onset and symptom overlap with other musculoskeletal disorders. This review focuses on emerging diagnostic strategies by synthesizing evidence specifically from studies that integrate biochemical biomarkers, advanced imaging techniques, and machine learning models relevant to osteoarthritis. We evaluate the diagnostic utility of cartilage degradation markers (e.g., CTX-II, COMP), inflammatory cytokines (e.g., IL-1β, TNF-α), and synovial fluid microRNA profiles, and how they correlate with quantitative imaging readouts from T2-mapping MRI, ultrasound elastography, and dual-energy CT. Furthermore, we highlight recent developments in radiomics and AI-driven image interpretation to assess joint space narrowing, osteophyte formation, and subchondral bone changes with high fidelity. The integration of these datasets using multimodal learning approaches offers novel diagnostic phenotypes that stratify patients by disease stage and risk of progression. Finally, we explore the implementation of these tools in point-of-care diagnostics, including portable imaging devices and rapid biomarker assays, particularly in aging and underserved populations. By presenting a unified diagnostic pipeline, this article advances the future of early detection and personalized monitoring in joint degeneration.

Musculoskeletal tumors present a diagnostic challenge due to their rarity, histological diversity, and overlapping imaging features. Accurate characterization is essential for effective treatment planning and prognosis, yet current diagnostic workflows rely heavily on invasive biopsy and subjective radiologic interpretation. This review explores the evolving role of radiogenomics and machine learning in improving diagnostic accuracy for bone and soft tissue tumors. We examine integrating quantitative imaging features from MRI, CT, and PET with genomic and transcriptomic data to enable non-invasive tumor profiling. AI-powered platforms employing convolutional neural networks (CNNs) and radiomic texture analysis show promising results in tumor grading, subtype differentiation (e.g., Osteosarcoma vs. Ewing sarcoma), and predicting mutation signatures (e.g., TP53, RB1). Moreover, we highlight the use of liquid biopsy and circulating tumor DNA (ctDNA) as emerging diagnostic biomarkers, coupled with point-of-care molecular assays, to enable early and accurate detection in low-resource settings. The review concludes by discussing translational barriers, including data harmonization, regulatory challenges, and the need for multi-institutional datasets to validate AI-based diagnostic frameworks. This article synthesizes current advancements and provides a forward-looking view of precision diagnostics in musculoskeletal oncology.

Advancements in load-bearing tissue repair increasingly demand biomaterials that not only support structural integrity but also interact dynamically with the physiological environment. This review examines the latest progress in smart biomaterials designed for skeletal reconstruction, with emphasis on mechanoresponsive scaffolds, bioactive composites, and integrated microsensors for real-time monitoring. We explore material formulations that enhance osseointegration, resist micromotion-induced loosening, and modulate inflammatory responses at the bone-implant interface. Additionally, we assess novel fabrication methods—such as additive manufacturing and gradient-based material deposition—for tailoring stiffness, porosity, and degradation profiles to match host biomechanics. Special attention is given to sensor-augmented platforms capable of detecting mechanical strain, biofilm formation, and early-stage implant failure. Together, these technologies promise a new class of bioresponsive, diagnostic-capable constructs that extend beyond static support to become active agents in regenerative healing and post-operative monitoring. This multidisciplinary review integrates insights from materials science, mechanobiology, and device engineering to inform the future of implantable systems in skeletal tissue repair.

Chronic low back pain (CLBP), frequently emanating from dynamic instability within the lumbar spine, constitutes a substantial global health challenge. While lumbosacral fusion remains a common surgical intervention for addressing this pathology, its inherent drawbacks, notably the acceleration of adjacent segment disease (ASD) at cephalad and caudal levels, the iatrogenic restriction of physiological intervertebral motion, and the potential for multifidus and erector spinae muscle atrophy, underscore the critical need for motion-preserving strategies. Here, we comprehensively review translational engineering advancements, particularly through mechanically tunable spinal implants and integrated intelligent sensor systems. We also thoroughly examine bioadaptive polymers and hybrid constructs that are being used in dynamic interspinous and interlaminar spacers, analyzing their time-dependent viscoelastic behavior and biomechanical compatibility through finite element modeling (FEM). Furthermore, we will explore the application of soft robotic principles to achieve personalized force modulation within innovative implant designs intended to dynamically stabilize the posterior elements, as well how microelectromechanical systems (MEMS) and nanosensors can help physicians with in-vivo monitoring of critical biomechanical parameters, including pedicle screw strain, intradiscal pressure within the nucleus pulposus and annulus fibrosus, and three-dimensional spinal kinematics across the instrumented segments. By doing so, our aim is to help clinicians and researchers alike seamlessly these integrate engineering solutions into everyday patient care.

Musculoskeletal disorders remain a major global cause of disability, with diagnostic complexity arising from their heterogeneous presentation and multifactorial pathophysiology. Recent advances across imaging modalities, molecular biomarkers, artificial intelligence applications, and point-of-care technologies are fundamentally reshaping musculoskeletal diagnostics. This review synthesizes emerging evidence on these innovations, emphasizing how integration of multimodal diagnostic strategies enables earlier detection, more accurate disease stratification, and increasingly personalized treatment planning. Technological developments in imaging—including photon-counting detector computed tomography, quantitative magnetic resonance imaging, and four-dimensional computed tomography—have enhanced the ability to visualize structural and dynamic musculoskeletal abnormalities with greater precision. Molecular imaging and biochemical markers such as CTX-II and PINP provide early, objective indicators of tissue degeneration and bone turnover, while genetic and epigenetic profiling elucidates individual susceptibility patterns. Point-of-care ultrasound and portable diagnostic devices have expanded real-time imaging and functional assessment capabilities across diverse clinical settings. Artificial intelligence and machine learning algorithms now automate image interpretation, predict clinical outcomes, and enhance clinical decision support, complementing conventional clinical evaluations. Wearable sensors and mobile health technologies extend continuous monitoring beyond traditional healthcare environments, generating real-world data critical for dynamic disease management. However, standardization of diagnostic protocols, rigorous validation of novel methodologies, and thoughtful integration of multimodal data remain essential to translate technological advances into improved patient outcomes. Addressing challenges in validation, equity, and cost-effectiveness will require coordinated efforts across research, clinical practice, industry, and regulatory bodies. As these fields converge, musculoskeletal diagnostics is poised to evolve into a more precise, personalized, and patient-centered discipline, driving meaningful improvements in musculoskeletal health worldwide.